Genex Pharmaceutical, Inc. (GENX) Stock Price & Growth Analysis

Quote Panel

Updated October 19, 2025

1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y 0.00 %

Key Metrics

Market Cap
1788
Shares Outstanding
17.88M
Share in Float
3.21M
Dividende
0

Earning Date
No Data
Price Target
0.0001
Average Volume
4556.96203
Beta
-0.83952886

Range
0.0001-0.0001
Industry
Drug Manufacturers - Specialty & Generic
Website
Sector
Healthcare

Quote Panel

Updated October 19, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.00x

P/S Ratio

0.00x

P/B Ratio

0.0

Debt/Equity

10.6%

Net Margin

$0.0

EPS

How GENX compares to sector?

P/E Ratio

Fundamentals

Relative Strength

GENX

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

GENX

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q3.05

N/A

NA
vs NA

Q4.05

N/A

NA
vs NA

Q1.06

N/A

NA
vs NA

Q2.06

N/A

NA
vs NA

Q3.06

N/A

NA
vs NA

Q4.06

N/A

NA
vs NA

Q1.07

N/A

NA
vs NA

Q2.07

N/A

NA
vs NA

Q3.07

N/A

NA
vs NA

Q4.07

N/A

NA
vs NA

Sales Growth

YoY

Current

Estimates

Q3.05

-3%

715.6K vs 741.4K

Q4.05

+10%

826.7K vs 751.3K

Q1.06

+41%

602.4K vs 428K

Q2.06

+3%

536.5K vs 521K

Q3.06

-13%

620.4K vs 715.6K

Q4.06

-18%

679K vs 826.7K

Q1.07

+22%

731.9K vs 602.4K

Q2.07

+40%

751.1K vs 536.5K

Q3.07

+39%

859.4K vs 620.4K

Q4.07

+32%

894.8K vs 679K

Return on Equity

QoQ

Q3.05

+10%

0.1
vs 0.08

Q4.05

-4%

-0.04
vs 0.1

Q1.06

+8%

0.08
vs -0.04

Q2.06

+0%

0
vs 0.08

Q3.06

+5%

0.05
vs 0

Q4.06

+4%

0.04
vs 0.05

Q1.07

+5%

0.05
vs 0.04

Q2.07

+3%

0.03
vs 0.05

Q3.07

+1%

0.01
vs 0.03

Q4.07

-2%

-0.02
vs 0.01

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q3.05

N/A

NA
vs NA

Q4.05

N/A

NA
vs NA

Q1.06

N/A

NA
vs NA

Q2.06

N/A

NA
vs NA

Q3.06

N/A

NA
vs NA

Q4.06

N/A

NA
vs NA

Q1.07

N/A

NA
vs NA

Q2.07

N/A

NA
vs NA

Q3.07

N/A

NA
vs NA

Q4.07

N/A

NA
vs NA

Sales Growth

YoY

Current

Estimates

Q3.05

-3%

715.6K vs 741.4K

Q4.05

+10%

826.7K vs 751.3K

Q1.06

+41%

602.4K vs 428K

Q2.06

+3%

536.5K vs 521K

Q3.06

-13%

620.4K vs 715.6K

Q4.06

-18%

679K vs 826.7K

Q1.07

+22%

731.9K vs 602.4K

Q2.07

+40%

751.1K vs 536.5K

Q3.07

+39%

859.4K vs 620.4K

Q4.07

+32%

894.8K vs 679K

Return on Equity

QoQ

Q3.05

+10%

0.1
vs 0.08

Q4.05

-4%

-0.04
vs 0.1

Q1.06

+8%

0.08
vs -0.04

Q2.06

+0%

0
vs 0.08

Q3.06

+5%

0.05
vs 0

Q4.06

+4%

0.04
vs 0.05

Q1.07

+5%

0.05
vs 0.04

Q2.07

+3%

0.03
vs 0.05

Q3.07

+1%

0.01
vs 0.03

Q4.07

-2%

-0.02
vs 0.01

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.00USD

N/A

0.00x

0.00x

0.0

10.6%

$0.0

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Latest News

Earnings Growth

Company Description

0.00USD

N/A

0.00x

0.00x

0.0

10.6%

$0.0

N/A

N/A

N/A